Skip to main content

Integrating the Envisia Genomic Classifier to Improve ILD Diagnostic & Prognostic Confidence

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Dr. Mary Beth Scholand

    Dr. Mary Beth Scholand, MD is an Associate Professor in Pulmonary Medicine at University of Utah . Her research and clinical interest is Interstitial Lung Disease. This interest encompasses Idiopathic Pulmonary Fibrosis, Autoimmune Lung Diseases and Sarcoidosis. She is the Director of the Interstitial Lung Disease Clinic. She runs clinical trials focused on a cure for Idiopathic Pulmonary Fibrosis. In addition, her research focuses on phenotypic factors and genetic factors associated with Chronic Obstructive Pulmonary Diseases and Interstitial Lung Diseases.

  • Dr. Fayez Kheir

    Dr. Fayez Kheir is the Director of Interventional Pulmonology research at Massachusetts General Hospital in Boston. He is an Assistant Professor at Harvard Medical School. He is board certified in internal medicine, pulmonary diseases, critical care, and interventional pulmonology and specializes in advanced interventional care and comprehensive general pulmonary care. Dr. Kheir treats a variety of complex airway disorders, lung nodules, pleural diseases, COPD and emphysema. His clinical interests include lung cancer diagnosis, lung nodules, pleural disease, severe emphysema and benign and malignant airway obstruction. He has served on numerous editorial boards and guidelines panel. Dr. Kheir is an active speaker and mentor and has written over 130 research and other peer-reviewed articles, letters to the editor, reviews, monographs, and editorials.

June 22, 2022
Wed 6:30 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
(888) 705-6002
+1 (858) 201-4136*
*for callers residing outside of the United States